НАСЛЕДСТВЕННЫЕ ФОРМЫ НЕФРОГЕННОГО НЕСАХАРНОГО ДИАБЕТА
https://doi.org/10.24884/1561-6274-2005-9-4-98-103
Аннотация
Наследственные формы нефрогенного несахарного диабета.
Об авторе
Н. Н. Смирнова
Санкт-Петербургский государственный медицинский университет им.акад. И.П. Павлова
Россия
Россия
Кафедра педиатрии
Список литературы
1. Багров ЯЮ. Нефрогенный несахарный диабет: пато генез и клинические варианты. Нефрология 1997;1(3): 1117
2. Van Lieburg AF, Knoers NV, Monnens LA. Congenital nephrogenic diabetes insipidus: a difficult diagnosis? Ned Tijdschr Geneeskd 1997; 141 (13): 609 – 612
3. Arthus MF et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with Xlinked nephrogenic diabetes insipidus. J Am Soc Nephrol 2000; 11 (6):1044 – 1054
4. Manning M, Cheng LL, Stoev S et al. Neurohypophysis: recent progress of vasopressin and oxytocin research. Amsterdam, 1995: 21 – 38
5. Иванова ЛН. Вазопрессин: клеточные и молекуляр ные аспекты антидиуретического действия. Вестник РАМН 1999; (3): 40 – 45
6. Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol 2001; 63: 607 – 630
7. Ishikawa SE. Nephrogenic diabetes insipidus with mutation of vasopressin V2 receptors and aquaporin2. Nippon Rinsho 2002; 60 (2): 350 – 355
8. Kamsteeg EJ, Deen PM, van Os CH. Defective processing and trafficking of water channels in nephrogenic diabetes insipidus. Exp Nephrol 2000; 8 (6): 326 – 331
9. Knoers NV, Deen PM. Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol 2001;16 (12): 1146 – 1152
10. Kamsteeg EJ, Wormhoudt TA, Rijss JP et al. An impaired routing of wildtype aquaporin2 after tetramerization with an aquaporin2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J 1999; 18(9): 2394 2400
11. Mulder SM, Bichet DG, Rijss JP et al. An aquaporin2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest 1998;102(1): 57 – 66
12. Marr N, Bichet DG, Lonergan M et al. Heteroligomerization of an aquaporin2 mutant with wildtype aquaporin2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus. Hum Mol Genet 2002 11 (7): 779 – 789
13. Kamsteeg EJ, Bichet DG, Konings IB et al. Reversed polarized delivery of an aquaporin2 mutant causes dominant nephrogenic diabetes insipidus. J Cell Biol 2003; 163(5): 1099 – 1109
14. Miyakoshi M, Kamoi K, Uchida S, Sasaki S. A case of a novel mutant vasopressin receptordependent nephrogenic diabetes insipidus with bilateral nonobstructive hydronephrosis in a middle age man: differentiation from aquaporindependent nephrogenic diabetes insipidus by response of factor V111 and von Willebrand factor to 1diamino8arginine vasopressin administration. Endocr J 2003; (6): 809 – 814
15. Van Lieburg AF, Knoers VV, Mallmann R et al. Normal fibrinolytic responses to 1desamino8arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin2 gene. Nephron 1996; 72 (4): 544 – 546
16. Kalenga K, Persu A, Goffin E et al. Intrafamilial phenotype variability in nephrogenic diabetes insipidus. Am J Kidney Dis 2002; 39(4): 737 – 743
17. Ala Y, Morin D, Mouillac B et al. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol 1998; 9(10): 1861 – 1872
18. VargasPoussou R, Forestier L, Dautzenberg MD et al. Mutation in the vasopressin V2 receptor and aquaporin2 genes in 12 families with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1997; 8 (12): 1855 – 1862
19. Rocha JL, Friedman E, Boson W et al. Molecular analyses of the vasopressin type 2 receptor amd aquaporin2 genes in Brazilian kinders with nephrogenic diabetes insipidus. Hum Mutat 1999; 14 (3): 233 – 239
20. Nomura Y, Onigata K, Nagashima T et al. Detection of skewed Xinactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 1997; 82 (10): 3434 – 3437
21. Van Lieburg AF, Verdijk MA, Schoute F et al. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet 1995; 96 (1):70 – 78
22. Sato K, Fukuno H, Taniguchi T et al. A novel mutation in the vasopressin V2 receptor gene in a woman with congenital nephrogenic diabetes insipidus. Intern Med 1999; 38 (10): 808 – 812
23. Pattaragrn A, Alon US. Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase2 inhibitor. Pediatr Nephrol 2003; 18 (10): 1073 – 1076
24. Van Lieburg AF, Knoers NV, Monnens LA. Clinical presentation and followup of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol – 1999; 10 (9): 1958 – 1964
25. Mizuno H, Sugiyama Y, Ohro Y et al. Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus. Endocrine 2004; 24(1): 55 – 59
26. Shalev H, Romanovsky I, Knoers NV et al. Bladder function impairment in aquaporin2 defective nephrogenic diabetes insipidus. Nephrol Dial Transplant 2004; 19 (3): 608 – 613
27. Glassberg KI. The valve bladder syndrome: 20 years later. J Urol 2001; 166 (4): 1406 – 1414
28. Fujii T, Ochi J, Miyajima T et al. Nephrogenic diabetes insipidus and tethered cord syndrome with a lipoma od the cauda. Brain Dev 1998; 20 (1): 47 – 49
29. Minami J, On K, Inada H et al. A case of congenital nephrogenic diabetes insipidus accompanied by hypertension. Nippon Jinzo Gakkai Shi 2001; 43 (1): 35 – 38
30. Owada M, Kawamura M, Kimura Y et al. Water intake and 24hour blood pressure monitoring in a patient with nephrogenic diabetes insipidus caused by a novel mutation of the vasopressin V2R gene. Intern Med 2002; 41 (2): 119 – 123
31. Hoekstra JA, van Lieburg AF, Monnens LA et al. Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 1996; 61(1): 81 – 88
32. Konoshita T, Kuroda M, Kawane T et al. Treatment of congenital nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride in an adult patient. Horm Res 2004; 61, (2): 63 – 67
33. Kirchlechner V, Koller DY, Seidl R, Waldhauser F. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride. Arch Dis Child 1999; 80(6): 548 – 552
34. Mizuno H., Fujimoto S., Sugiyama Y et al. Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin. Horm Res 2003; 59(6): 297 – 300
35. Muller D, Marr N, Ankermann T et al. Desmopressin for noctural enuresis in nephrogenic diabetes insipidus. Lancet 2002; 359 (93305) (9): 495 – 497
36. Morello JP, PetajaRepo UE, Bichet DG, Bouvier M. Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol Sci 2000; 21(12): 466 – 469
37. Schneberg T, Yun J, Wenkert D, Wess J. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a coexpressed receptor polypeptide. EMBO J 1996; 15 (6): 1283 – 1291
Рецензия
Для цитирования:
Смирнова Н.Н. НАСЛЕДСТВЕННЫЕ ФОРМЫ НЕФРОГЕННОГО НЕСАХАРНОГО ДИАБЕТА. Нефрология. 2005;9(4):98-103. https://doi.org/10.24884/1561-6274-2005-9-4-98-103
For citation:
Smirnova N.N. HEREDITARY FORMS OF NEPHROGENIC DIABETES INSIPIDUS. Nephrology (Saint-Petersburg). 2005;9(4):98-103. (In Russ.) https://doi.org/10.24884/1561-6274-2005-9-4-98-103
Просмотров:
241
Послать статью по эл. почте 